People

Joshua D. Fox

Partner

Fox_Joshua_lo.jpg

Joshua Fox is a leading corporate attorney representing companies in various stages of their lifecycle, from startups to established corporations, with particular emphasis on life sciences and other emerging technology companies, including software, internet and hardware companies. Since joining the firm in 2001, Mr. Fox has counseled numerous entrepreneurs and companies, from prior to the formation of a business entity through an exit event, and regularly advises clients on seed-stage, venture capital, strategic and other financings. He also advises clients in various other transactions, including mergers and acquisitions and public offerings.

Mr. Fox provides advice to companies with respect to incorporation and startup, angel and venture capital financings, mergers and acquisitions, public offerings, securities law compliance and general corporate matters. As a member of the Emerging Company and Venture Capital Practice, Mr. Fox focuses on the representation of early-stage companies, counseling entrepreneurs on the formation of their businesses and serving as counsel to those businesses, including in their initial public offerings and their acquisitions by other corporations. Learn more about Mr. Fox's practice and how he can support your startup on WilmerHaleLaunch.com.

Highlights

Public Offerings and PIPE Transactions

  • Aileron Therapeutics, Inc. in its initial public offering 
  • ConforMIS, Inc. in its initial public offering
  • Karyopharm Therapeutics Inc. in its initial public offering
  • AVEO Pharmaceuticals, Inc. in its initial public offering, its private placement of common stock in November 2010, and its private placement of common stock to Johnson & Johnson Development Corporation
  • Infinity Pharmaceuticals, Inc. in its public offering of common stock in December 2012
  • Alnylam Pharmaceuticals, Inc. in its initial public offering

Mergers and Acquisitions

  • Orbitera, Inc. in its sale to Google
  • Aciex Therapeutics, Inc. in its sale to Nicox S.A.
  • Aegis Lightwave, Inc. in its sale to II-VI Incorporated, and its previous acquisitions of CardinalPoint Optics, Inc. and AOFR Pty Limited
  • Infinity Pharmaceuticals, Inc. in its reverse merger with Discovery Partners International, Inc.
  • SkyPhrase in its sale to Yahoo
  • AccuRev in its sale to Micro Focus
  • Axiom Global Inc. in its acquisition of LawyerLink
  • Imagitas, Inc. in its sale to Pitney Bowes Inc.

Venture Capital and Other Financings

  • Aquinnah Pharmaceuticals, Inc. 
  • Asimov Inc.
  • Hydra Biosciences, Inc.
  • Casa Systems, Inc.
  • Karyopharm Therapeutics Inc. (prior to it becoming a public company)
  • AVEO Pharmaceuticals, Inc. (prior to it becoming a public company)
  • Infinity Pharmaceuticals, Inc. (prior to it becoming a public company)
  • Aciex Therapeutics, Inc. (prior to its sale)
  • Aegis Lightwave, Inc. (prior to its sale)

Honors & Awards

  • Recommended in the 2016 edition of The Legal 500 United States for finance: capital markets: equity offerings: advice to managers
  • Named a "New England Super Lawyers Rising Star" in corporate law in the 2008, 2010-2016 issues of Boston Magazine
  • Civil Rights Recognition Award Recipient from the Lawyers' Committee for Civil Rights Under Law of the Boston Bar Association (2010)

Publications

  • "When to Let Your Competitors Be Your Investors," VentureBeat (September 16, 2017)
  • "Startup M&A: Why a Letter of Intent Deserves Your Full Attention," Xconomy (June 28, 2016)
  • "Five Things You Should Know About Founder Stock Vesting," WilmerHale Launch Blog (October 5, 2015)
  • "When Should Your Biosciences Startup Use an NDA?" NYC Tech Connect and the EIR for NYC Blog (November 13, 2012)
  • "Mistakes Made By Founders of Startup Companies: Advice To Entrepreneurs," Entrepreneurship@BU Newsletter (November 2012)
  • "Founders Stock, Part 1," NYC Tech Connect and the EIR for NYC blog (June 5, 2012)
  • "When Should My Bioscience Startup Move Out of the Academic Lab?" NYC Tech Connect and the EIR for NYC blog (March 13, 2012)
  • "When Should I Incorporate My Bioscience Startup?" NYC Tech Connect and the EIR for NYC blog (February 1, 2012)
  • "Attorneys' View: Tips On Bringing In VC funds," Mass High Tech (May 1, 2009)
  • "Convertible Debt Financing Is A Key Fund-Raising Tool," Boston Business Journal, Banking/Financial Services Quarterly (September 12- 18, 2008)
  • "Don't Overvalue Pre-Money Valuations," TieCon East Conference Publication (June 2007)
  • "Don't Overvalue Premoney Valuations on Term Sheets," Mass High Tech (March 2, 2007)

Speaking Engagements

Mr. Fox is a frequent guest lecturer on a variety of topics.

  • Financings: What Entrepreneurs Need to Know – Harvard University – Private Equity Course – July 25, 2017
  • Hiring Your First Employees and Advisors and Letting Them Go When Necessary – WilmerHale QuickLaunch University Webinar, July 20, 2017
  • Building the Legal Infrastructure – Tufts Entrepreneurial Leadership Program – Tufts University, March 4, 2017
  • Venture Capital in Asia – Harvard Business School – 2017 Asia Business Conference, March 4, 2017
  • Financing a Startup – Broad Institute of MIT and Harvard – Biomedical Entrepreneurship Course, January 26, 2017
  • Best Practices for Building a Board of Directors and Board of Advisors – WilmerHale QuickLaunch University: Successfully Launching Your Startup, September 13, 2016
  • Entrepreneurship, Investment and the Greater Good – 2016 Harvard Law Entrepreneurship Project Conference – Harvard Law School, April 9, 2016
  • Venture Capital Financings – 2016 Transaction Practice Conference – Boston University School of Law, March 1, 2016
  • Swedish-American Life Tech Forum – Swedish American Chamber of Commerce-New England, October 13-15, 2015  
  • Knowing Your Exits – Harvard iLab, August 12, 2015  
  • Financing Deal Structures and Term Sheets: Advice to Entrepreneurs – Healthbox, April 16, 2015
  • Launch Smart Clinic – MIT Enterprise Forum, April 2, 2015 
  • One size does not fit all – Financing in the Health and Sciences Market – Harvard iLab, December 4, 2014
  • Intellectual Property and Your Startup Company – Northeastern University IDEA Lab, January 30, 2014

Publications & News

View

October 3, 2017

WilmerHale Counsels Suono Bio in Seed Funding Led by Polaris and MIT’s The Engine

Suono Bio, a company developing a platform technology designed to enable ultra-rapid delivery of therapeutics—including proteins and nucleic acids—to the gastrointestinal tract, has announced that it has raised its seed funding round from Polaris, MIT's “The Engine” and other investors.

September 16, 2017

When to Let Your Competitors Be Your Investors

Partner Joshua Fox, in this guest article published by VentureBeat, discusses the benefits and risks of entrepreneurs seeking capital from competitors, also known as “strategic investors.”

July 6, 2017

WilmerHale Represents Aileron Therapeutics in IPO

Aileron Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a novel class of therapeutics called stapled peptides for cancers and other diseases, announced the pricing of its initial public offering.

April 25, 2017

WilmerHale Counsels Aquinnah Pharmaceuticals in $10M Investment From Pfizer and AbbVie

Aquinnah Pharmaceuticals announced that Pfizer Inc. and AbbVie Inc. have invested in their work to treat Amyotrophic Lateral Sclerosis, Alzheimer's disease and other neurodegenerative diseases.

September 22, 2016

Matchmaker, Matchmaker, Find Me A Lawyer

Partner Josh Fox is quoted by To Market in this September 2016 article discussing Legal Food Hub's initiative to pair farmers and food entrepreneurs with volunteer attorneys.

August 10, 2016

WilmerHale Advises Orbitera in Acquisition by Google

The Google Cloud Platform team shares Orbitera's vision for seamless purchase and deployment of IT services across heterogeneous cloud infrastructure.

June 22, 2016

The Legal 500 United States 2016 Recognizes 111 WilmerHale Lawyers Across 30 Practice Areas

The guide's rankings are based on a series of criteria, including client feedback, interviews with private practice lawyers, and its own research.

February 21, 2014

WilmerHale Again Named Among Boston’s Most Admired Law Firms

For the second consecutive year, the Boston Business Journal honored WilmerHale as a "Most Admired Law Firm" in the Boston area.

September 27, 2013

Law360 Names WilmerHale Pro Bono Firm of the Year for Second Consecutive Year

For the second consecutive year, Law360 selected WilmerHale to its "Pro Bono Firms of the Year" list for notable successes.

November 1, 2012

Mistakes Made By Founders of Start-Up Companies: Advice To Entrepreneurs

An article by Joshua Fox, published in the November 2012 Entrepreneurship@BU Newsletter.

Professional Activities

  • WilmerHale's Hiring Committee, Member
  • WilmerHale's Pro Bono and Community Service Committee, Member
  • WilmerHale's Boston Office Summer Program, Co-Chair
  • Life Sciences Alliance of the Greater Boston Chamber of Commerce, Member
  • Northeastern University D'Amore-McKim School of Business Board of Visitors, Member

Community Involvement

  • Dana-Farber Cancer Institute Leadership Council, Member 
  • Tufts University Alumni Council, Executive Committee Member
  • Tufts Lawyers Association Board of Directors, Past Member
  • Tufts Lawyers Association, Past President

Practices

Skip Navigation Links.

Education

JD, Harvard Law School, 2001

BA, Political Science, summa cum laude, Tufts University, 1998, Phi Beta Kappa

Bar Admissions

Massachusetts

New York

Skip Navigation Links.